Evolent Health Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for Evolent Health stock have an average target of 6.29, with a low estimate of 3.00 and a high estimate of 10. The average target predicts an increase of 14.16% from the current stock price of 5.51.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.00	$6.29	$6.00	$10
Change	-45.55%	+14.16%	+8.89%	+81.49%

Analyst Ratings

The average analyst rating for Evolent Health stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	11	10	10	10	10	9
Buy	4	4	4	4	4	4
Hold	1	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	16	16	16	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jailendra Singh Truist Financial	Truist Financial	Buy Maintains $6 → $7	Buy	Maintains	$6 → $7	+27.04%	Jun 12, 2026
Ryan Daniels William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 15, 2026
Daniel Grosslight Citi	Citi	Buy Maintains $4 → $5.5	Buy	Maintains	$4 → $5.5	-0.18%	May 15, 2026
Richard Close Canaccord Genuity	Canaccord Genuity	Buy Maintains $5 → $6	Buy	Maintains	$5 → $6	+8.89%	May 12, 2026
Charles Rhyee TD Cowen	TD Cowen	Buy Maintains $7 → $8	Buy	Maintains	$7 → $8	+45.19%	May 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

2.50B

from 1.88B

33.32%

from 1.88B

Revenue Next Year

2.95B

from 2.50B

18.04%

from 2.50B

EPS This Year

0.20

from 0.09

118.38%

from 0.09

EPS Next Year

0.38

from 0.20

95.84%

from 0.20

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	907.96M	1.35B	1.96B	2.55B	1.88B	2.50B	2.95B
Revenue Growth	-1.80%	48.91%	45.26%	30.09%	-26.56%	33.32%	18.04%
EPS	-0.44	-0.20	-1.28	-0.81	-5.07	-0.73	-0.55
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	2.6B	3.2B
Avg	2.5B	3.0B
Low	2.4B	2.7B

Revenue Growth

Revenue Growth	2026	2027
High	39.2%	26.3%
Avg	33.3%	18.0%
Low	29.7%	6.8%

EPS Forecast

EPS	2026	2027
High	0.26	0.47
Avg	0.20	0.38
Low	0.13	0.16

EPS Growth

EPS Growth	2026	2027
High	188.9%	139.1%
Avg	118.4%	95.8%
Low	44.4%	-18.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.